
Cost of Hepatitis C Drugs Anger Patients; CBCD Reviews a Report
The drug's high cost is the source of a growing debate among healthcare professionals, drug makers, and patients. (1) ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, July 20, 2015 /EINPresswire.com/ -- “Infected with the hepatitis C virus (HCV)? …